Vaxxinity Financials

We advise to exercise Vaxxinity fundamental analysis to find out if markets are presently mispricing the firm. In other words this technique allows you to confirm available indicators of Vaxxinity as well as the relationship between them. We have analyzed and interpolated thirty-one available drivers for Vaxxinity, which can be compared to its competition.
  
Please note, the imprecision that can be found in Vaxxinity's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Vaxxinity. Check Vaxxinity's Beneish M Score to see the likelihood of Vaxxinity's management manipulating its earnings.

Vaxxinity Stock Summary

Vaxxinity competes with Tarsus Pharmaceuticals, Aldeyra, Travere Therapeutics, Eton Pharmaceuticals, and Structure Therapeutics. Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas. Vaxxinity Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people.
Specialization
Healthcare, Biotechnology
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
ISINUS92244V1044
CUSIP92244V104
LocationTexas; U.S.A
Business Address505 Odyssey Way,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.vaxxinity.com
Phone254 244 5739
CurrencyUSD - US Dollar

Vaxxinity Key Financial Ratios

Vaxxinity's financial ratios allow both analysts and investors to convert raw data from Vaxxinity's financial statements into concise, actionable information that can be used to evaluate the performance of Vaxxinity over time and compare it to other companies across industries.

Vaxxinity Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Vaxxinity's current stock value. Our valuation model uses many indicators to compare Vaxxinity value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vaxxinity competition to find correlations between indicators driving Vaxxinity's intrinsic value. More Info.
Vaxxinity is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vaxxinity by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vaxxinity's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Vaxxinity Thematic Clasifications

Vaxxinity is part of Pharmaceutical Products investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
Pharmaceutical ProductsView
This theme covers USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Consideration for investing in Vaxxinity Pink Sheet

If you are still planning to invest in Vaxxinity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaxxinity's history and understand the potential risks before investing.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Stocks Directory
Find actively traded stocks across global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges